147 related articles for article (PubMed ID: 25978364)
1. Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine.
Liang T; Alloosh M; Bell LN; Fullenkamp A; Saxena R; Van Alstine W; Bybee P; Werling K; Sturek M; Chalasani N; Masuoka HC
PLoS One; 2015; 10(5):e0124173. PubMed ID: 25978364
[TBL] [Abstract][Full Text] [Related]
2. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Lee L; Alloosh M; Saxena R; Van Alstine W; Watkins BA; Klaunig JE; Sturek M; Chalasani N
Hepatology; 2009 Jul; 50(1):56-67. PubMed ID: 19434740
[TBL] [Abstract][Full Text] [Related]
3. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.
Panasevich MR; Meers GM; Linden MA; Booth FW; Perfield JW; Fritsche KL; Wankhade UD; Chintapalli SV; Shankar K; Ibdah JA; Rector RS
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E78-E92. PubMed ID: 28899857
[TBL] [Abstract][Full Text] [Related]
4. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
5. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
6. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.
Charlton M; Krishnan A; Viker K; Sanderson S; Cazanave S; McConico A; Masuoko H; Gores G
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G825-34. PubMed ID: 21836057
[TBL] [Abstract][Full Text] [Related]
7. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
8. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
[TBL] [Abstract][Full Text] [Related]
9. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
10. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.
Kristiansen MN; Veidal SS; Rigbolt KT; Tølbøl KS; Roth JD; Jelsing J; Vrang N; Feigh M
World J Hepatol; 2016 Jun; 8(16):673-84. PubMed ID: 27326314
[TBL] [Abstract][Full Text] [Related]
11. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
12. Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Bell LN; Lee L; Saxena R; Bemis KG; Wang M; Theodorakis JL; Vuppalanchi R; Alloosh M; Sturek M; Chalasani N
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G746-54. PubMed ID: 20167877
[TBL] [Abstract][Full Text] [Related]
13. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.
Henkel J; Coleman CD; Schraplau A; Jӧhrens K; Weber D; Castro JP; Hugo M; Schulz TJ; Krämer S; Schürmann A; Püschel GP
Mol Med; 2017 May; 23():70-82. PubMed ID: 28332698
[TBL] [Abstract][Full Text] [Related]
14. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM
PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539
[TBL] [Abstract][Full Text] [Related]
16. A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis.
Ichimura M; Masuzumi M; Kawase M; Sakaki M; Tamaru S; Nagata Y; Tanaka K; Suruga K; Tsuneyama K; Matsuda S; Omagari K
J Nutr Biochem; 2017 Feb; 40():62-69. PubMed ID: 27863346
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
19. A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
Miyaoka Y; Jin D; Tashiro K; Masubuchi S; Ozeki M; Hirokawa F; Hayashi M; Takai S; Uchiyama K
Exp Anim; 2018 May; 67(2):239-247. PubMed ID: 29311502
[TBL] [Abstract][Full Text] [Related]
20. Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.
Ding ZM; Xiao Y; Wu X; Zou H; Yang S; Shen Y; Xu J; Workman HC; Usborne AL; Hua H
Front Pharmacol; 2018; 9():410. PubMed ID: 29765319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
